Skip to Main Content

Paper Details

Cardiovascular and renal outcomes among patients with type 2 diabetes using SGLT2 inhibitors added to metformin: a population-based cohort study from the UK.
BMJ Open Diabetes Res Care
4
2023
CV death, IS, MI, SGLT2, SGLT2i, SGLT2is, chronic kidney disease, glucose, ischemic stroke, metformin, patient, patients, renal disease, sodium, sodium-glucose co-transporter-2, type 2 diabetes
Author NameAffiliation
David VizcayaBayer Pharmaceuticals
David VizcayaBayer Pharmaceuticals
Luis A García RodríguezSpanish Centre for Pharmacoepidemiologic Research (CEIFE)
  • 1 - 3

Datasets

Release 1.2